SIP
CCXI

Stoneridge Investment Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Stoneridge Investment Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-41,355
Closed -$239K – 236
2013
Q4 		$239K Buy
41,355
+3,800
+10% +$19.6K 0.05% 172
2013
Q3 		$209K Buy
+37,555
New +$406K 0.05% 180

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stoneridge Investment Partners's CCXI Position: Q1 2014 in Review

Stoneridge Investment Partners sold out of ChemoCentryx, Inc. (CCXI) in Q1 2014, closing a stake of 41,355 shares — an estimated $239K sold.

Stoneridge Investment Partners first reported a position in CCXI in Q3 2013 and held it in 2 quarters. The position peaked at $239K in Q4 2013. 65 funds tracked by Wall St. Rank hold CCXI as of Q1 2014.

  • Stoneridge Investment Partners reported no remaining ChemoCentryx, Inc. position as of Q1 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 41,355 ChemoCentryx, Inc. shares in Q1 2014, an estimated $239K.
  • Stoneridge Investment Partners first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 2 quarters.
  • Stoneridge Investment Partners's ChemoCentryx, Inc. position peaked at $239K in Q4 2013.
  • 65 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2014.

Based on Stoneridge Investment Partners's 13F filing for Q1 2014, filed 15 Apr 2014.